A detailed history of Schrum Private Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Schrum Private Wealth Management LLC holds 16,620 shares of ABBV stock, worth $2.76 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
16,620
Previous 10,555 57.46%
Holding current value
$2.76 Million
Previous $1.81 Million 81.33%
% of portfolio
1.7%
Previous 1.64%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $993,689 - $1.21 Million
6,065 Added 57.46%
16,620 $3.28 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $3,869 - $4,519
-25 Reduced 0.24%
10,555 $1.81 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $412,335 - $469,818
2,580 Added 32.25%
10,580 $1.93 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $354,870 - $399,667
-2,579 Reduced 24.38%
8,000 $1.24 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $132 - $164
1 Added 0.01%
10,579 $1.43 Million
Q1 2023

Apr 19, 2023

SELL
$144.61 - $166.54 $261,021 - $300,604
-1,805 Reduced 14.58%
10,578 $1.69 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $148,406 - $177,978
-1,073 Reduced 7.97%
12,383 $0
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $143,067 - $164,089
-1,066 Reduced 7.34%
13,456 $1.81 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $5,939 - $7,368
45 Added 0.31%
14,522 $2.3 Million
Q4 2021

Mar 11, 2022

BUY
$107.43 - $135.93 $1.56 Million - $1.97 Million
14,477 New
14,477 $1.96 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Schrum Private Wealth Management LLC Portfolio

Follow Schrum Private Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schrum Private Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schrum Private Wealth Management LLC with notifications on news.